৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.



Products
Payment
Delivery
Indications
Inj. K MM (Vitamin K-1) is indicated in following indications-
· Prophylaxis and treatment of haemorrhagic disease in the newborn.
. Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of
courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders,
and after prolonged treatment with antibiotics, sulphonamides or salicylates).
. Prevention and treatment of bleeding due to vitamin K deficiency.
Pharmacology
Phytomenadione is a procoagulant factor. As a component of a hepatic carboxylase system, Phytomenadione is involved in the post translational carboxylation of clotting factors II
(prothrombin), VII, IX and X and the clotting inhibitors protein C and protein S. Phytomenadione is ineffective in hereditary hypoprothrombinemia or hypoprothrombinemia induced by
severe hepatic failure. Lack of Phytomenadione leads to an increased tendency to haemorrhagic disease in the newborn. Phytomenadione administration, which promotes synthesis of
the above-mentioned coagulation factors by the liver, can reverse an abnormal coagulation status and bleeding due to Phytomenadione deficiency.
Dosage & Administration
Prophylaxis: Mild Hemorrhage or hemorrhagic tendency: The usual dose for Neonates is 2 mg orally at or just after birth. Then 2 mg on 4th-5th day and another 2 mg on 28th-30th day
orally. If the oral route is unsuitable then 2 mg of drug can be administered by IM or IV route.
Children over 1 year of age: Could be given 5-10 mg orally. A single 1 mg (0.1 ml) dose IM is recommended in children who are not assured of receiving a second oral dose or, in the case
of breast-fed children, who are not assured of receiving a third oral dose.
Therapy: Initially, 1 mg by intravenous injection, with further doses as required, based on the clinical picture and coagulation status.
KMM 10 mg Injection is a medicine used to treat vitamin K deficiency in the body. It helps in improving conditions caused due to low levels of vitamin K in the body. Vitamin K is an important nutrient which is necessary for blood clotting and bone metabolism.\n\nKMM 10 mg Injection is given under the supervision of a healthcare professional and should not be self-administered. You should take it regularly to get the most benefit from it. This medicine may be only part of a complete program of treatment that also includes making changes to your diet and taking vitamin supplements.\n\nKMM 10 mg Injection is generally safe with little or no side effects. However, it may cause pain, redness or swelling at the site of injection in some people.\n\nBefore taking this medicine, let your doctor know all other medicines you are taking to make sure you are safe. It is important to ask advise of the doctor before taking any other vitamin supplements.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
KMM 10 mg Injection is a synthetic form of vitamin K. It restores the activity of vitamin K and speeds up the normal blood clotting process to prevent or treat bleeding caused due to too high dose of warfarin.





